Atlas Trials

Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Amisodin in Healthy Adult Subjects With Amyotrophic Lateral Sclerosis

Clinical trial NCT07221240 · RECRUITING

Trial details

NCT number
NCT07221240
Sponsor
PRG Science & Technology Co., Ltd.
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Amyotrophic Lateral Sclerosis
Start date
2025-10-01
Primary completion
2026-05-27
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.